NO20004215D0 - A pharmaceutical composition comprising an angiotensin II type 2 receptor agonist, and use thereof - Google Patents

A pharmaceutical composition comprising an angiotensin II type 2 receptor agonist, and use thereof

Info

Publication number
NO20004215D0
NO20004215D0 NO20004215A NO20004215A NO20004215D0 NO 20004215 D0 NO20004215 D0 NO 20004215D0 NO 20004215 A NO20004215 A NO 20004215A NO 20004215 A NO20004215 A NO 20004215A NO 20004215 D0 NO20004215 D0 NO 20004215D0
Authority
NO
Norway
Prior art keywords
angiotensin
type
pharmaceutical composition
receptor agonist
agonist
Prior art date
Application number
NO20004215A
Other languages
Norwegian (no)
Other versions
NO20004215L (en
Inventor
Lars Fondriks
Anders Pettersson
Anders Hallberg
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Publication of NO20004215D0 publication Critical patent/NO20004215D0/en
Publication of NO20004215L publication Critical patent/NO20004215L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20004215A 1998-02-24 2000-08-23 A pharmaceutical composition comprising an angiotensin II type 2 receptor agonist, and use thereof NO20004215L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9800550A SE9800550D0 (en) 1998-02-24 1998-02-24 A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
PCT/SE1999/000262 WO1999043339A1 (en) 1998-02-24 1999-02-24 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof

Publications (2)

Publication Number Publication Date
NO20004215D0 true NO20004215D0 (en) 2000-08-23
NO20004215L NO20004215L (en) 2000-09-18

Family

ID=20410283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004215A NO20004215L (en) 1998-02-24 2000-08-23 A pharmaceutical composition comprising an angiotensin II type 2 receptor agonist, and use thereof

Country Status (18)

Country Link
EP (1) EP1066048A1 (en)
JP (1) JP2002504516A (en)
KR (1) KR20010041211A (en)
CN (1) CN1291104A (en)
AU (1) AU755949B2 (en)
BR (1) BR9908188A (en)
CA (1) CA2319123A1 (en)
EE (1) EE200000481A (en)
HU (1) HUP0101411A3 (en)
ID (1) ID26639A (en)
IL (1) IL137990A0 (en)
IS (1) IS5594A (en)
MX (1) MXPA00008172A (en)
NO (1) NO20004215L (en)
NZ (1) NZ506188A (en)
SE (1) SE9800550D0 (en)
SK (1) SK11522000A3 (en)
WO (1) WO1999043339A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821953B1 (en) 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
AU1793101A (en) * 1999-12-16 2001-06-25 University Of Southern California Methods for treating and preventing damage to mucosal tissue
AU2002257970B2 (en) 2001-05-31 2007-08-02 Vicore Pharma Ab Tricyclic compounds useful as angiotensin II agonists
AU2006235698B2 (en) 2005-04-12 2012-03-29 Vicore Pharma Ab New tricyclic angiotensin II agonists
DE602006018122D1 (en) 2005-04-12 2010-12-23 Vicore Pharma Ab NEW TRICYCLIC ANGIOTENSIN II AGONISTS
JP5179349B2 (en) 2005-04-12 2013-04-10 ヴィコール・ファルマ・アーベー Novel bicyclic angiotensin II agonist
KR101423898B1 (en) * 2005-12-14 2014-07-28 암브룩스, 인코포레이티드 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
US8835471B2 (en) 2010-06-11 2014-09-16 Vicore Pharma Ab Use of angiotensin II agonists
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
US20150119329A1 (en) * 2012-04-16 2015-04-30 New York University Modulation of angiotensin ii receptors for the prevention and treatment of malaria cerebral
MX2017010993A (en) 2015-03-02 2018-04-11 Vicore Pharma Ab Angiotensin ii receptor agonist for treating pulmonary fibrosis.
WO2017221012A1 (en) 2016-06-21 2017-12-28 Vicore Pharma Ab Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity
GB201818164D0 (en) 2018-11-07 2018-12-19 Vicore Pharma Ab New composition
US20220257698A1 (en) 2019-08-02 2022-08-18 Lanthiopep B.V. Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer
GB201913603D0 (en) 2019-09-20 2019-11-06 Vicore Pharma Ab New compounds
KR20230004501A (en) 2020-03-19 2023-01-06 바이코어 파마 아베 New Compounds Useful for the Treatment and/or Prevention of Diseases, Disorders, or Conditions Associated with Angiotensin II
GB202004094D0 (en) 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
GB202006081D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006074D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006079D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202013721D0 (en) 2020-09-01 2020-10-14 Vicore Pharma Ab New compounds
EP4313953A1 (en) 2021-03-23 2024-02-07 Vicore Pharma AB Selective angiotensin ii receptor ligands
GB202104033D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
GB202104038D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
AU2022306778A1 (en) 2021-07-09 2024-01-18 Vicore Pharma Ab New selective angiotensin ii compounds
GB202115303D0 (en) 2021-10-25 2021-12-08 Vicore Pharma Ab New formulation
WO2023152503A1 (en) 2022-02-10 2023-08-17 Vicore Pharma Ab Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis
GB202201723D0 (en) 2022-02-10 2022-03-30 Vicore Pharma Ab New use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444067A (en) * 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
WO1996014060A1 (en) * 1994-11-04 1996-05-17 Marklund Stefan L Use of receptor agonists to stimulate superoxide dismutase activity
SE9501881D0 (en) * 1995-05-19 1995-05-19 Astra Ab New pharmacological use of AII receptor antagonists
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
SE9502219D0 (en) * 1995-06-19 1995-06-19 Astra Ab Novel medical use

Also Published As

Publication number Publication date
KR20010041211A (en) 2001-05-15
BR9908188A (en) 2000-10-24
NZ506188A (en) 2003-04-29
HUP0101411A3 (en) 2002-11-28
EP1066048A1 (en) 2001-01-10
IS5594A (en) 2000-08-21
IL137990A0 (en) 2001-10-31
MXPA00008172A (en) 2002-06-21
HUP0101411A2 (en) 2002-03-28
NO20004215L (en) 2000-09-18
SK11522000A3 (en) 2001-04-09
JP2002504516A (en) 2002-02-12
AU2753799A (en) 1999-09-15
EE200000481A (en) 2002-02-15
CA2319123A1 (en) 1999-09-02
CN1291104A (en) 2001-04-11
SE9800550D0 (en) 1998-02-24
ID26639A (en) 2001-01-25
AU755949B2 (en) 2003-01-02
WO1999043339A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
NO20004215D0 (en) A pharmaceutical composition comprising an angiotensin II type 2 receptor agonist, and use thereof
NO306398B1 (en) Substituted N- (indole-2-carbonyl) glycinamides, their use, intermediate and pharmaceutical composition
DK1019077T4 (en) New exendin agonist compounds
PT1177178E (en) SUBSTITUTED HETERICYLIC BENZIMIDAZOES, THEIR PREPARATION AND APPLICATION
NO305435B1 (en) Estrogen agonist / antagonists, pharmaceuticals containing them and intermediates thereof
NO20043803L (en) Substituted amides active in the cannabinoid 1 receptor
NO20001612D0 (en) Oral preparation
NO20012411D0 (en) Pyrrolidine derivatives-CCR-3 receptor antagonists
NO994906L (en) GnRH antagonists modified at positions 5 and 6
NO20001160L (en) New foam-forming pharmaceutical preparation
CY2013008I1 (en) APPETITE SUPPRESSANT PEPTIDE, COMPOSITIONS AND USE THEREOF
IT1312366B1 (en) COPOLYMERIC RESIN, ITS PREPARATION AND PHOTORESIST USING IT.
DK0733626T3 (en) N- (Benzofurazanyl) -arylsulfonamides and analogs thereof which can be used as endothelin receptor antagonists
NO306257B1 (en) 11- (substituted phenyl) -ostra-4,9-diene derivatives, pharmaceutical composition and use thereof
NO20005399L (en) Pharmaceutical preparation
DK199900176U3 (en) Paroxetine salts, pharmaceutical preparation containing these and uses thereof
EP1112252A4 (en) Kappa agonist compounds and pharmaceutical formulations thereof
NO20006138D0 (en) Substituted indolinones, preparation and use thereof as drugs
NO996115D0 (en) Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
NO20004668D0 (en) 1- (3-heteroarylpropyl- or -prop-2-enyl) -4-benzylpiperidines used as NMDA receptor antagonists
DK1237559T3 (en) Pharmaceutical combinations comprising a P2T receptor antagonist and melagatran
NO20004274D0 (en) Protease-activated receptor 4 and its use
NO20004277D0 (en) Indole derivatives and pharmaceutical compositions comprising the same
MA26890A1 (en) EESTROGEN AGONIST / ANTAGONIST METABOLITES
NO20012727L (en) 3,4,5-trisubstituted arylnitron compounds and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application